+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Heart Failure Drug"

Heart Failure Drugs - Global Strategic Business Report - Product Thumbnail Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • July 2026
  • 155 Pages
  • Global
From
From
From
Medications for Heart Failure Market Report 2026 - Product Thumbnail Image

Medications for Heart Failure Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Heart Failure Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Heart Failure Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Vericiguat API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Vericiguat API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
From
From
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • July 2026
  • 458 Pages
  • Global
From
From
From
Loading Indicator

The Heart Failure Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat a variety of heart-related conditions. Heart Failure Drugs are used to treat heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. These drugs can help reduce symptoms, improve quality of life, and reduce the risk of death. Commonly used Heart Failure Drugs include ACE inhibitors, beta blockers, diuretics, and angiotensin receptor blockers. These drugs work by reducing the workload on the heart, improving blood flow, and reducing fluid buildup in the body. Some companies in the Heart Failure Drug market include Pfizer, Novartis, Merck, Sanofi, and Bristol-Myers Squibb. Show Less Read more